Pacira Pharmaceuticals buy Royal Bank of Canada
Start price
01.03.23
/
50%
€40.00
Target price
01.03.24
€71.20
Performance (%)
-34.50%
End price
02.03.24
€26.20
Summary
This prediction ended on 02.03.24 with a price of €26.20. The BUY prediction by Royal_Bank_of_Canada for Pacira Pharmaceuticals performed very badly with a performance of -34.50%. Royal_Bank_of_Canada has a follow-up prediction for Pacira Pharmaceuticals where he still thinks Pacira Pharmaceuticals is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pacira Pharmaceuticals | -3.817% | -3.817% | -29.213% |
iShares Core DAX® | 0.238% | -2.265% | 13.679% |
iShares Nasdaq 100 | -0.304% | 5.808% | 34.538% |
iShares Nikkei 225® | 2.271% | 1.577% | 9.436% |
iShares S&P 500 | -0.296% | 4.447% | 28.577% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Royal Bank of Canada from $80.00 to $76.00. They now have an "outperform" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€34.80
03.08.23
03.08.23
€62.07
03.08.24
03.08.24
-27.59%
27.06.24
27.06.24
Stopped prediction by Royal_Bank_of_Canada for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
01.03.24
01.03.24
€41.56
01.03.25
01.03.25
-2.29%
27.06.24
27.06.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
03.11.23
03.11.23
€54.04
03.11.24
03.11.24
-6.34%
27.06.24
27.06.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€27.40
03.10.23
03.10.23
€65.04
03.10.24
03.10.24
-6.57%
27.06.24
27.06.24